Glenda Gray to Cost-Benefit Analysis
This is a "connection" page, showing publications Glenda Gray has written about Cost-Benefit Analysis.
Connection Strength
0,094
-
Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ. 1999 Jun 19; 318(7199):1650-6.
Score: 0,036
-
Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012. BMC Public Health. 2016 Apr 14; 16:330.
Score: 0,029
-
The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis. Medicine (Baltimore). 2016 Jan; 95(4):e2528.
Score: 0,028